Malaria is a serious public health problem worldwide. Globally concerted efforts are underway to control and eliminate it. Despite recent slowdown, substantial achievements have been recorded in the last 20 years. However, its eradication requires successful elimination of all Plasmodium parasites among symptomatic, asymptomatic, and sub-microscopic infections. This review is aimed at assessing the role of molecular diagnostic tools in malaria elimination. Quality assured malaria diagnosis is fundamental to control and elimination of malaria. High-throughput molecular diagnostic tools are important for the diagnosis, and monitoring of interventions to mitigate malaria. Molecular techniques such as real-time PCR, LAMP, nPCR, RT-PCR, multiplex-PCR, NASBA, and CLIP-PCR have been instrumental for malaria control and elimination. They enabled the detection and identification of symptomatic, asymptomatic, and sub-microscopic parasitemia. They are also important in the discovery, and development of drugs. Despite their tremendous contribution and immense potential, they are not readily available in malaria-endemic settings, fail to detect hypnozoites and infectious gametocytes as well as not sufficiently optimized for fieldwork. Those challenges might delay malaria elimination thereby threatening the quest to reach the goal of a malaria-free world by 2050. Therefore, we need novel tools fit for field application and for detecting hypnozoites, infectious gametocytes, and in vitro analysis of Plasmodium vivax.
| Published in | International Journal of Clinical and Experimental Medical Sciences (Volume 9, Issue 1) |
| DOI | 10.11648/j.ijcems.20230901.12 |
| Page(s) | 7-20 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Malaria Elimination, Recurrence, Molecular Diagnostic Tools, Polymerase Chain Reaction, Plasmodium
| [1] | World Health Organization: Global Malaria Programme. WHO Malaria Terminology. Geneva: WHO; 2019. |
| [2] | World Health Organization. A Framework for Malaria Elimination. Geneva: WHO; 2017. |
| [3] | Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, et al. A research agenda to underpin malaria eradication. PLoS Med. 2011; 8 (1): e1000406. |
| [4] | World Health Organization. Guidelines for Malaria Vector Control. Geneva: WHO; 2019. |
| [5] | World Health Organization. WHO Guidelines for Malaria. Geneva: WHO; 2021. |
| [6] | World Health Organization. Global Technical Strategy for Malaria 2016-2030: Update. Geneva: WHO; 2021. |
| [7] | Meibalan E, Marti M. Biology of malaria transmission. Cold Spring Harb Perspect Med. 2017; 7 (3): a025452-a. |
| [8] | World Health Organization: International Health Regulations. Vector Surveillance and Control at Ports, Airports, and Ground Crossings. Geneva: WHO; 2016. |
| [9] | World Health Organization. Malaria Surveillance, Monitoring, and Evaluation a Reference Manual. Geneva: WHO; 2018. |
| [10] | World Health Organization, Medicines for Malaria Venture. Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations. Informal consultation organized by the Medicines for Malaria Venture and co-sponsored by the World Health Organization; Amsterdam: WHO; 2008. |
| [11] | Garrido-Cardenas JA, González-Cerón L, Manzano-Agugliaro F, Mesa-Valle C. Plasmodium genomics: an approach for learning about and ending human malaria. Parasitol Res. 2019; 118 (1): 1-27. |
| [12] | Girma S, Cheaveau J, Mohon AN, Marasinghe D, Legese R, Balasingam N, et al. Prevalence and Epidemiological Characteristics of asymptomatic Malaria Based on Ultrasensitive Diagnostics: A Cross-sectional Study. Clin Infect Dis. 2018; 69 (6): 1003-10. |
| [13] | Zheng Z, Cheng Z. Advances in Molecular Diagnosis of Malaria. In: Makowski GS, editor. Adv Clin Chem. 80. Burlington: Elsevier Inc.; 2017; 155-92. |
| [14] | World Health Organization. World Malaria Report 2021. Geneva: WHO; 2021. |
| [15] | Imwong M, Hanchama S, Malleret B, Renia L, Day N, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014; 52 (9): 3303-9. |
| [16] | Cheng Z, Wang D, Tian X, Sun Y, Sun X, Xiao N, et al. Capture and Ligation Probe-PCR (CLIP-PCR) for Molecular Screening, with Application to Active Malaria Surveillance for Elimination. Clin Chem. 2015; 61 (6): 821- 8. |
| [17] | Nyarko PB, Claessens A. Understanding Host-Pathogen-Vector Interactions with Chronic Asymptomatic Malaria Infections. Trends in Parasitology. 2021; 37 (3): 195-204. |
| [18] | The malERA Refresh Consultative Panel on Characterizing the Reservoir and Measuring Transmission. An updated research agenda for characterizing the reservoir and measuring transmission in malaria elimination and eradication. PLoS Med. 2017; 14 (11): e1002452. |
| [19] | Wesolowski A, Taylor AR, Chang HH, Verity R, Tessema S, Bailey J, et al. Mapping malaria by combining parasite genomic and epidemiologic data. BMC Med. 2018; 16 (1): 1-8. |
| [20] | World Health Organization: Global Malaria Programme. Report on antimalarial drug efficacy, resistance, and response: 10 years of surveillance (2010-2019). Geneva: WHO; 2020. |
| [21] | Nsanzabana C. Time to scale up molecular surveillance for antimalarial drug resistance in sub-Saharan Africa. Malar J. 2021; 20 (401). |
| [22] | Ganeshan H, Kusi KA, Anum D, Hollingdale MR, Peters B, Kim Y, et al. Measurement of ex vivo ELISpot interferon-gamma recall responses to P. falciparum AMA1 and CSP in Ghanaian adults with natural exposure to malaria. Malar J. 2016; 15. |
| [23] | Clark D. Molecular Biology. Oxford: Elsevier Academic Press; 2005. |
| [24] | Perandin F. Development of a real-time PCR assay for detection of P. falciparum, P. vivax, and P. ovale for routine clinical diagnosis. J Clin Microbiol. 2004; 42 (3): 1214-9. |
| [25] | Khan WA, Galagan SR, Prue CS, Khyang J, Ahmed S, Ram M, et al. Asymptomatic P. falciparum malaria in pregnant women in the Chittagong Hill District of Bangladesh. PLoS One. 2014; 9 (5): e98442. |
| [26] | Kralik P, Ricchi M, Donu D. A Basic Guide to Real-time PCR in Microbial Diagnostics: Definitions, Parameters, and Everything. Front Microbiol. 2017; 8 (108). |
| [27] | ThermoFisher Scientific. Real-time PCR handbook 2021 [Available from: https://www.thermofisher.com/qpcr. |
| [28] | Haanshuus CG, Mørch K, Blomberg B, Strøm GEA, Langeland N, Hanevik K, et al. Assessment of malaria real-time PCR methods and application with a focus on low-level parasitemia. PLoS One. 2019; 14 (7): 1-15. |
| [29] | Beshir KB, Diallo N, Sutherland CJ. Identifying recrudescent P. falciparum in treated malaria patients by real-time PCR and high-resolution melt analysis of genetic diversity. Sci Rep. 2018; 8 (1): 1-10. |
| [30] | Tedla M. A focus on improving molecular diagnostic approaches to malaria control and elimination in low transmission settings: Review. Parasite Epidemiology and Control. 2019; 6: e00107. |
| [31] | Osei J, Govinden U, Essack S. Review of established and innovative detection methods for carbapenemase-producing Gram-negative bacteria. J Appl Microbiol. 2015; 119: 1219- 33. |
| [32] | Homann MV, Emami SN, Yman V, Stenstrom C, Sonden K, Ramstrom H, et al. Detection of malaria parasites after treament in Travelers: A 12-months longitudinal study and statistical modeling analysis. EBioMedicine. 2017; 2017 (25): 66-72. |
| [33] | Snounou G, Singh B. Nested PCR Analysis of Plasmodium Parasites. In: Methods Molecular Medicine. editor: Doolan DL. 72. Totowa: Humana Press; 2002. |
| [34] | Encyclopedia of Malaria. New York: Springer Science+Business Media; 2013. |
| [35] | Marcus MB. The hypnozoite concept, with particular reference to malaria. Parasitol Res. 2011; 108: 247-52. |
| [36] | Plasmodium vivax Information Hub. Knowledge sharing for relapsing malaria. Focus on: Relapse, Reinfection or Recrudescence 2021 [Available from: www.vivaxmalaria.org. |
| [37] | Snounou G. Genotyping of Plasmodium species: Nested PCR. In: Methods in Molecular Medicine. Malaria Methods and Protocols. editor: Doolan DL. 72. Totowa: Humana Press Inc; 2002. |
| [38] | Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. Detection of a substantial number of sub-microscopic P. falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia. Malar J. 2013; 13 (352). |
| [39] | Abamecha A, Yilma D, Addisu W, El-Abid H, Ibenthal A, Noedl H, et al. Therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated P. falciparum malaria in Chewaka District, Ethiopia. Malar J. 2020; 19 (1): 1-10. |
| [40] | Zhao Y, Zhao Y, Lv Y, Liu F, Wang Q, Li P, et al. Comparison of methods for detecting asymptomatic malaria infections in the China-Myanmar border area. Malar J. 2017; 16 (159). |
| [41] | Markus MB. Biological concepts in recurrent P. vivax malaria. Parasitology. 2018: 1-7. |
| [42] | Chavatte JM, Tan SBH, Snounou G, Lin RTPV. Molecular characterization of misidentified P. ovale imported cases in Singapore. Malar J. 2015; 14 (454). |
| [43] | European Union. Guidance document on multiplex real-time PCR methods. Publications Office of the European Union. Luxembourg; EU; 2021. |
| [44] | Leski TA, Taitt CR, Swaray AG, Bangura U, Reynolds ND, Holtz A, et al. Use of real-time multiplex PCR, malaria rapid diagnostic test and microscopy to investigate the prevalence of Plasmodium species among febrile hospital patients in Sierra Leone. Malar J. 2020; 19 (84). |
| [45] | Belachew M, Wolde M, Nega D, Gidey B, Negash L, Assefa A, et al. Evaluating Performance of multiplex PCR. Malar J. 2022; 21 (1). |
| [46] | Rubio J, Benito A, Roche J, Berzosa P, Garcia M, Mico M, et al. Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of P. vivax infection in Equatorial Guinea. Am J Trop Med Hyg. 1999; 60: 183- 7. |
| [47] | Methods in Molecular Medicine. Malaria Methods and Protocols. editor: Doolan DL. Totowa: Humana Press; 2017. |
| [48] | Methods in Molecular Biology. Reverse Transcription Polymerase Chain Reaction (RT-PCR) Protocols: 2nd edition: Humana Press; 2010. |
| [49] | Fan H, Robetorye RS. Real-time Quantitative Reverse Transcriptase Polymerase Chain Reaction: RT-PCR Protocols. 2nd edition. Methods in Molecular Biology: Springer Science+Business Media; 2010. |
| [50] | Wampfler R, Mwingira F, Javati S, Robinson L, Betuela I, Siba P, et al. Strategies for Detection of Plasmodium species Gametocytes. PLoS One. 2013; 8 (9): 76316. |
| [51] | Pritsch M, Wieser A, Soederstroem V, Poluda D, Eshetu T, Hoelscher M, et al. Stability of gametocyte-specific Pfs25 mRNA in dried blood spots on filter paper subjected to different storage conditions. Malar J. 2012; 11 (138). |
| [52] | Obaldı´a N, Barahona I, Lasso J, Avila M, Quijada M, Nuñez M, et al. Comparison of PvLAP5 and Pvs25 qRT-PCR assays for the detection of P. vivax gametocytes in field samples preserved at ambient temperature from remote malaria-endemic regions of Panama. PLOS Neglected Tropical Disease. 2022; 16 (4): e0010327. |
| [53] | Ouédraogo AL, Gonçalves BP, Gnémé A, Wenger EA, Guelbeogo MW, Ouédraogo A, et al. Dynamics of the Human Infectious Reservoir for Malaria Determined by Mosquito Feeding Assays and Ultrasensitive Malaria Diagnosis in Burkina Faso. The Journal of Infectious Diseases. 2016; 213 (1): 90-9. |
| [54] | Babiker HA, Schneider P. Application of molecular methods for monitoring transmission stages of malaria parasites. Biomed Mater. 2008; 3: 034007. |
| [55] | Schneider P, Reece SE, Schaijk BCLv, Bousema T, Lanke KHW, Meaden CSJ, et al. Quantification of female and male P. falciparum gametocytes by reverse transcriptase quantitative PCR. Mol Biochem Parasitol. 2015; 199 (2015): 29-33. |
| [56] | Murphy S. Real-time quantitative reverse transcription PCR for monitoring of blood-stage P. falciparum infections in malaria human challenge trials. Am J Trop Med Hyg. 2021; 86 (3): 383-94. |
| [57] | Chawla J, Oberstaller J, Adams JH. Targeting gametocytes of the malaria parasite P. falciparum in a functional genomics era: Next steps. Pathogens. 2021; 10 (3): 1-22. |
| [58] | Recker M, Bull PC, Buckee CO. Recent advances in the molecular epidemiology of clinical malaria. F1000Research. 2018; 7. |
| [59] | Schneider P, Wolters L, Schoone G. Real-time nucleic acid sequence-based amplification is more convenient than real-time PCR for quantification of P. falciparum. J Clin Microbiol. 2005; 43: 402-5. |
| [60] | Schneider P, Schoone G, Schallig H, Verhage D, Telgt D, Eling W, et al. Quantification of P. falciparum gametocytes in differential stages of development by quantitative nucleic acid sequence-based amplification. Mol Biochem Parasitol. 2004; 137 (2004): 35-41. |
| [61] | Bousema JT, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, et al. Revisiting the circulation time of P. falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010; 9 (136). |
| [62] | Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, et al. Sub-microscopic P. falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007; 76 (3): 470-4. |
| [63] | Shekalaghe SA, Bousema T, Kunei KK, Lushino P, Masokoto A, Wolters LR, et al. Sub-microscopic P. falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Trop Med Int Health. 2007; 12 (4): 547-53. |
| [64] | Mawili-Mboumba DP, Nikiéma R, Bouyou-Akotet MK, Bahamontes-Rosa N, Traoré A, Kombila M. Sub-microscopic gametocyte carriage in febrile children living in different areas of Gabon. Malar J. 2013; 12 (375). |
| [65] | Omar SA, Mens PF, Schoone GJ, Yusuf A, Mwangi J, Kaniaru S, et al. P. falciparum: Evaluation of a quantitative nucleic acid sequence-based amplification assay to predict the outcome of Sulfadoxine-Pyrimethamine treatment of uncomplicated malaria. Exp Parasitol. 2005; 110 (2005): 73-9. |
| [66] | Schneider P, Bousema T, Omar S, Gouagna L, Sawa P, Schallig H, et al. (Sub) microscopic P. falciparum gametocytemia in Kenyan children after treatment with sulphadoxine-pyrimethamine monotherapy or in combination with artesunate. Int J Parasitol. 2006; 36 (2006): 403-8. |
| [67] | Premier Biosoft. Accelerating Research in Life Science. NASBA Technology: An overview: Premier Biosoft; 2021 [Available from: https://:www.premierbiosoft.com. |
| [68] | Mawili-Mboumba DP, Ndong RN, Rosa NB, Largo JLL, Lembet-Mikolo A, Nzamba P, et al. Sub-microscopic Falciparum Malaria in Febrile Individuals in Urban and Rural Areas of Gabon. Am J Trop Med Hyg. 2017; 96 (4): 815-8. |
| [69] | Oriero EC, Jacobs J, Geertruyden J-PV, Nwakanma D, D'Alessandro U. Molecular-based isothermal tests for field diagnosis of malaria and their potential contribution to malaria elimination. J Antimicrob Chemother. 2014; 70 (1): 2-13. |
| [70] | Pett H, Gonçalves BP, Dicko A, Nébié I, Tiono AB, Lanke K, et al. Comparison of molecular quantification of P. falciparum gametocytes by Pfs25 qRT-PCR and QT-NASBA in relation to mosquito infectivity. Malar J. 2016; 15 (539). |
| [71] | Mbanefo A, Kumar N. Evaluation of Malaria Diagnostic Methods as a Key for Successful Control and Elimination Programs. Tropical Medicine and Infectious Disease. 2020; 5 (2). |
| [72] | Poon LL, Wong BW, Ma EH, Chan KH, Chow LM, Abeyewickreme W, et al. Sensitive and inexpensive molecular test for falciparum malaria: detecting P. falciparum DNA directly from heat-treated blood by loop-mediated isothermal amplification. Clinical Chemistry. 2006; 52: 303-6. |
| [73] | Han ET, Watanabe R, Sattabongkot J, Khuntirat B, Sirichaisinthop J, Iriko H, et al. Detection of four Plasmodium species by genus- and species-specific loop-mediated isothermal amplification for clinical diagnosis. J Clin Microbiol. 2007; 45 (8): 2521-8. |
| [74] | Vásquez AM, Zuluaga L, Tobón A, Posada M, Vélez G, González IJ, et al. Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening malaria in peripheral and placental blood samples from pregnant women in Colombia. Malar J. 2018; 17 (262). |
| [75] | Ahmad F, Hashsham S A. Miniaturized nucleic acid amplification systems for rapid and point of care diagnostics: A review. Anal Chim Acta. 2012; 733 (1-15). |
| [76] | UNITAID. Malaria diagnostic technology landscape: semi-annual update. Geneva: UNITAID; 2012. |
| [77] | Tegegne B, Getie S, Lemma W, Mohon AN, Pillai DR. Performance of loop-mediated isothermal amplification (LAMP) for the diagnosis of malaria among malaria suspected pregnant women in Northwest Ethiopia. Malar J. 2017; 16 (34). |
| [78] | Zimmerman PA. Nucleic Acid Surveillance and Malaria Elimination. Clin Chem. 2015; 61 (6): 789-91. |
| [79] | World Health Organization. World Malaria Report 2020: 20 years of global progress and challenges. Geneva. WHO; 2020. |
| [80] | The malERA Refresh Consultative Panel on Basic Science and Enabling Technologies malERA. An updated research agenda for basic science and enabling technologies in malaria elimination and eradication. PLoS Med. 2017; 14 (11): e1002451. |
| [81] | Wampfler R, Timinao L, Beck H. Novel genotyping tools for investigating transmission dynamics of P. falciparum. J Infect Dis. 2014; 210 (8): 1188-97. |
| [82] | Otto TD, Bohme U, Jackson AP, Hunt M, Franke-Fayard B, Hoeijmakers WA, et al. A comprehensive evaluation of rodent malaria parasite genomes and gene expression. BMC Biology. 2014; 12 (86). |
| [83] | Yamagishi J, Natori A, Tolba ME, Mongan AE, Sugimoto C, Katayama T, et al. Interactive transcriptome analysis of malaria patients and infecting P. falciparum. Genome Res. 2014; 24 (9): 1433- 44. |
| [84] | Kaneko I, Iwanaga S, Kato T, Kobayashi I, Yuda M. Genome-Wide Identification of the Target Genes of AP2-O, a Plasmodium AP2-Family Transcription Factor. PLoS Pathog. 2015; 11 (5): e1004905. |
| [85] | World Health Organization. World Malaria Day 2021. Reaching the zero malaria target. Communications Toolkit. Geneva. WHO; 2021. |
| [86] | Flannery EL, Fidock DA, Winzeler EA. Using genetic methods to define the targets of compounds with antimalarial activity. J Med Chem. 2013; 56 (20): 7761-71. |
| [87] | Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant P. falciparum malaria. Nature. 2014; 505 (7481): 50- 5. |
| [88] | Baragana B, Hallyburton I, Lee MC, Norcross NR, Grimaldi R, Otto TD, et al. A novel multiple-stage antimalarial agent that inhibits protein synthesis. Nature. 2015; 522 (7556): 315-20. |
| [89] | Bopp SE, Manary MJ, Bright AT, Johnston GL, Dharia NV, Luna FL, et al. Mitotic evolution of P. falciparum shows a stable core genome but recombination in antigen families. PLoS Genet. 2013; 9 (2): e1003293. |
| [90] | Sutherland CJ, Hallett R. Detecting Malaria Parasites outside the Blood. The Journal of Infectious Diseases. 2009; 199: 1561-3. |
| [91] | Singh R, Singh DP, Gupta R, Savargaonkar D, Singh OP, Nanda N, et al. Comparison of three PCR-based assays for the non-invasive diagnosis of malaria: detection of Plasmodium parasites in blood and saliva. Eur J Clin Microbiol Infect Dis. 2014; 33 (9): 1631-9. |
| [92] | Kast K, Berens-Riha N, Zeynudin A, Abduselam N, Eshetu T, Löscher T, et al. Evaluation of P. falciparum gametocyte detection in different patient material. Malar J. 2013; 12 (438): 1-9. |
| [93] | Baird JK, Valecha N, Duparc S, White NJ, Price RN. Diagnosis and treatment of P. vivax malaria. Am J Trop Med Hyg. 2016; 95 (Suppl 6): 35-51. |
| [94] | Baird JK. Malaria caused by P. vivax: Recurrent, difficult to treat, disabling, and threatening to life- Averting the infectious bite preempts these hazards. Pathogens and Global Health. 2013; 107 (8): 475-9. |
| [95] | World Health Organization. World Malaria Report 2020: 20 Years of Global Progress and Challenges. Geneva: WHO; 2021. |
| [96] | White MT, Karl S, Battle KE, Hay SI, Mueller I, Ghani AC. Modeling the contribution of the hypnozoite reservoir to P. vivax transmission. eLife. 2014. |
| [97] | World Health Organization. Testing for G-6-PD deficiency for safe use of primaquine in radical cure of P. vivax and P. ovale malaria: Policy Brief. Geneva. WHO; 2016. |
| [98] | World Health Organization. Confronting P. vivax Malaria. Geneva. WHO; 2015. |
| [99] | The malERA Refresh Consultative Panel on Tools for Malaria Elimination malERA. An updated research agenda for diagnostics, drugs, vaccines, and vector control in malaria elimination and eradication. PLoS Medicine 2017; 14 (11): e1002455. |
| [100] | Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. P. vivax in the Era of the Shrinking P. falciparum Map. Trends in Parasitology 2020; 36 (6): 560-70. |
| [101] | World Health Organization. Malaria eradication: benefits, future scenarios, and feasibility. A report of the Strategic Advisory Group on Malaria Eradication. Geneva; WHO; 2019. |
APA Style
Aklilu Alemayehu. (2023). Molecular Diagnostic Tools and Malaria Elimination: A Review on Solutions at Hand, Challenges Ahead and Breakthroughs Needed. International Journal of Clinical and Experimental Medical Sciences, 9(1), 7-20. https://doi.org/10.11648/j.ijcems.20230901.12
ACS Style
Aklilu Alemayehu. Molecular Diagnostic Tools and Malaria Elimination: A Review on Solutions at Hand, Challenges Ahead and Breakthroughs Needed. Int. J. Clin. Exp. Med. Sci. 2023, 9(1), 7-20. doi: 10.11648/j.ijcems.20230901.12
AMA Style
Aklilu Alemayehu. Molecular Diagnostic Tools and Malaria Elimination: A Review on Solutions at Hand, Challenges Ahead and Breakthroughs Needed. Int J Clin Exp Med Sci. 2023;9(1):7-20. doi: 10.11648/j.ijcems.20230901.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcems.20230901.12,
author = {Aklilu Alemayehu},
title = {Molecular Diagnostic Tools and Malaria Elimination: A Review on Solutions at Hand, Challenges Ahead and Breakthroughs Needed},
journal = {International Journal of Clinical and Experimental Medical Sciences},
volume = {9},
number = {1},
pages = {7-20},
doi = {10.11648/j.ijcems.20230901.12},
url = {https://doi.org/10.11648/j.ijcems.20230901.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcems.20230901.12},
abstract = {Malaria is a serious public health problem worldwide. Globally concerted efforts are underway to control and eliminate it. Despite recent slowdown, substantial achievements have been recorded in the last 20 years. However, its eradication requires successful elimination of all Plasmodium parasites among symptomatic, asymptomatic, and sub-microscopic infections. This review is aimed at assessing the role of molecular diagnostic tools in malaria elimination. Quality assured malaria diagnosis is fundamental to control and elimination of malaria. High-throughput molecular diagnostic tools are important for the diagnosis, and monitoring of interventions to mitigate malaria. Molecular techniques such as real-time PCR, LAMP, nPCR, RT-PCR, multiplex-PCR, NASBA, and CLIP-PCR have been instrumental for malaria control and elimination. They enabled the detection and identification of symptomatic, asymptomatic, and sub-microscopic parasitemia. They are also important in the discovery, and development of drugs. Despite their tremendous contribution and immense potential, they are not readily available in malaria-endemic settings, fail to detect hypnozoites and infectious gametocytes as well as not sufficiently optimized for fieldwork. Those challenges might delay malaria elimination thereby threatening the quest to reach the goal of a malaria-free world by 2050. Therefore, we need novel tools fit for field application and for detecting hypnozoites, infectious gametocytes, and in vitro analysis of Plasmodium vivax.},
year = {2023}
}
TY - JOUR T1 - Molecular Diagnostic Tools and Malaria Elimination: A Review on Solutions at Hand, Challenges Ahead and Breakthroughs Needed AU - Aklilu Alemayehu Y1 - 2023/03/24 PY - 2023 N1 - https://doi.org/10.11648/j.ijcems.20230901.12 DO - 10.11648/j.ijcems.20230901.12 T2 - International Journal of Clinical and Experimental Medical Sciences JF - International Journal of Clinical and Experimental Medical Sciences JO - International Journal of Clinical and Experimental Medical Sciences SP - 7 EP - 20 PB - Science Publishing Group SN - 2469-8032 UR - https://doi.org/10.11648/j.ijcems.20230901.12 AB - Malaria is a serious public health problem worldwide. Globally concerted efforts are underway to control and eliminate it. Despite recent slowdown, substantial achievements have been recorded in the last 20 years. However, its eradication requires successful elimination of all Plasmodium parasites among symptomatic, asymptomatic, and sub-microscopic infections. This review is aimed at assessing the role of molecular diagnostic tools in malaria elimination. Quality assured malaria diagnosis is fundamental to control and elimination of malaria. High-throughput molecular diagnostic tools are important for the diagnosis, and monitoring of interventions to mitigate malaria. Molecular techniques such as real-time PCR, LAMP, nPCR, RT-PCR, multiplex-PCR, NASBA, and CLIP-PCR have been instrumental for malaria control and elimination. They enabled the detection and identification of symptomatic, asymptomatic, and sub-microscopic parasitemia. They are also important in the discovery, and development of drugs. Despite their tremendous contribution and immense potential, they are not readily available in malaria-endemic settings, fail to detect hypnozoites and infectious gametocytes as well as not sufficiently optimized for fieldwork. Those challenges might delay malaria elimination thereby threatening the quest to reach the goal of a malaria-free world by 2050. Therefore, we need novel tools fit for field application and for detecting hypnozoites, infectious gametocytes, and in vitro analysis of Plasmodium vivax. VL - 9 IS - 1 ER -
Email: